Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Methyl Salicylate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.49 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CFTR | P13569 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA7 | P43166 | 3/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Salicylate SCHEMBL27476177 | 0.90 | LMNA (0.73) | LMNATSHRADRB2ADRB1ADRB3 | |
| Dimethyl Phthalate SCHEMBL11141565 | 0.90 | TSHR (0.55) | LMNATSHRKDM4EGLAALDH1A1 | |
| Methyl Salicylate SCHEMBL28507609 | 0.90 | LMNA (0.85) | LMNATSHRADRB2ADRB1ADRB3 | |
| Mannitol SCHEMBL21522528 | 0.87 | LMNA (0.69) | LMNATSHRADRB2ADRB1ADRB3 | |
| Mannitol SCHEMBL21522526 | 0.87 | LMNA (0.69) | LMNATSHRADRB2ADRB1ADRB3 | |
| Methyl Salicylate SCHEMBL27571018 | 0.86 | LMNA (0.85) | LMNATSHRTDP1KDM4EGLA | |
| Methyl Salicylate SCHEMBL4113789 | 0.86 | LMNA (0.85) | LMNATSHRTDP1KDM4EGLA | |
| Methyl Salicylate SCHEMBL29370254 | 0.86 | LMNA (1.00) | LMNATSHRTDP1KDM4EALDH1A1 | |
| Methyl Salicylate SCHEMBL1872042 | 0.86 | LMNA (1.00) | LMNATSHRTDP1KDM4EALDH1A1 | |
| Methyl Salicylate SCHEMBL5312 | 0.86 | LMNA (1.00) | LMNATSHRTDP1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106259453-A | A kind of compositions preventing and treating wheat sawfly and preparation method thereof | 项正威 | 2017-01-04 | — | — | CN | claimed |
| CN-106259453-A | A kind of compositions preventing and treating wheat sawfly and preparation method thereof | 项正威 | 2017-01-04 | — | — | CN | disclosed |
| CN-1547475-B | Dermal therapy using phosphate derivatives of electron transfer agents | VITAL HEALTH SCIENCES PTY LTD | 2010-12-15 | — | — | CN | disclosed |
| CN-1547475-A | Dermal therapy using phosphate derivatives of electron transfer agents | �Ϻ���ͨ��ѧ | 2004-11-17 | — | — | CN | disclosed |
| EP-0525055-A4 | IMPROVED IONTOPHORETIC ADMINISTRATION OF DRUGS | — | 1993-10-06 | — | — | EP | disclosed |
| EP-0525055-A1 | IMPROVED IONTOPHORETIC ADMINISTRATION OF DRUGS | GENSIA PHARMACEUTICALS, INC. (US) | 1993-02-03 | — | — | EP | disclosed |
| WO-1991016103-A1 | IMPROVED IONTOPHORETIC ADMINISTRATION OF DRUGS | GENSIA PHARMACEUTICALS, INC. (US) | 1991-10-31 | — | — | WO | disclosed |